 - Measurable disease defined by RECIST v. 1.1 or evaluable disease defined as solid andor cystic abnormalities on radiographic imaging that do not meet RECIST 1.1 definitions for target lesions OR ascites andor pleural effusion that has been pathologically demonstrated to be disease related in the setting of cancer antigen CA25 2 x upper limit of normal ULN 